Identifying Early Markers for Breast Cancer
Author Information
Author(s): Kretschmer Céline, Sterner-Kock Anja, Siedentopf Friederike, Schoenegg Winfried, Schlag Peter M, Kemmner Wolfgang
Primary Institution: Charité Comprehensive Cancer Center
Hypothesis
Can we identify molecular markers that allow early detection of ductal carcinoma in situ (DCIS) in breast cancer?
Conclusion
The study identified seven genes that may help in the early detection of DCIS and invasive breast carcinomas.
Supporting Evidence
- Seven genes were significantly up-regulated in DCIS-bearing mice.
- Similar up-regulation of these genes was observed in human DCIS samples.
- Quantitative RT-PCR confirmed the enhanced expression of the identified marker genes.
Takeaway
The researchers found some genes that can help doctors catch breast cancer early, which is really important for treating it successfully.
Methodology
Gene expression profiling was performed on transgenic mice and human samples, followed by validation using quantitative RT-PCR and immunohistochemistry.
Potential Biases
Potential bias due to the limited sample size and reliance on specific mouse models.
Limitations
The study was limited by the small number of human DCIS samples available for analysis.
Participant Demographics
The human cohort consisted of nine DCIS, five invasive ductal carcinoma (IDC), and five healthy control samples.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website